AG
RXRX icon

Algert Global’s Recursion Pharmaceuticals RXRX Stock Holding History

Algert Global’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$819K Sell
223,237
-373,640
-63% -$1.24M 0.01% 998
2026
Q1 		$1.83M Sell
596,877
-67,666
-10% -$261K 0.03% 735
2025
Q4 		$2.72M Buy
+664,543
New +$3.29M 0.04% 622
2024
Q3 		– Sell
-17,158
Closed -$129K – 1531
2024
Q2 		$129K Buy
+17,158
New +$150K ﹤0.01% 1359

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Algert Global's RXRX Position: Q2 2026 in Review

Algert Global reduced its Recursion Pharmaceuticals (RXRX) stake by 63% in Q2 2026, selling an estimated $1.24M and leaving 223,237 shares worth $819K. The position accounts for 0.01% of the portfolio, ranked #998.

Algert Global first reported a position in RXRX in Q2 2024 and has held it in 4 quarters since. The position peaked at $2.72M in Q4 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Algert Global held 223,237 shares of Recursion Pharmaceuticals worth $819K as of Q2 2026.
  • Algert Global sold 373,640 Recursion Pharmaceuticals shares in Q2 2026, an estimated $1.24M.
  • Recursion Pharmaceuticals made up 0.01% of Algert Global's portfolio in Q2 2026, its #998 holding.
  • Algert Global first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
  • Algert Global's Recursion Pharmaceuticals position peaked at $2.72M in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.